# Eosinophilic Granulomatosis With Polyangiitis Presenting as a Mononeuritis Multiplex Mimicking Guillain-Barré Syndrome

**Authors:** Mohamad Zikir Ismail, Fathin Hadi, Wan Syamimee Wan Ghazali, Bazli Md Yusoff

PMC · DOI: 10.7759/cureus.98202 · Cureus · 2025-11-30

## TL;DR

A woman with a history of allergies was misdiagnosed with Guillain-Barré syndrome but later found to have a rare autoimmune condition called EGPA, which responded well to steroid treatment.

## Contribution

This case highlights the diagnostic challenge of distinguishing EGPA from GBS in patients with acute neuropathy.

## Key findings

- Initial diagnosis of Guillain-Barré syndrome was incorrect; the patient was later diagnosed with EGPA.
- The patient showed significant neurological improvement with corticosteroid therapy and methotrexate.
- Systemic features like asthma, eosinophilia, and vasculitic signs are crucial for accurate diagnosis.

## Abstract

A 41-year-old Malay woman with a background of allergic rhinitis, nasal polyps, and eczema presented with bilateral foot numbness and weakness. Neurological examination revealed bilateral foot drop and sensory loss over the L5-S1 dermatomes. Nerve conduction studies showed bilateral peroneal and tibial axonal neuropathy. She was initially diagnosed with Guillain-Barré syndrome (GBS) and treated with intravenous immunoglobulin (IVIG), but showed no clinical improvement. Further evaluation revealed pansinusitis on CT imaging, vasculitic rashes, marked eosinophilia of 8.7 × 10⁹/L, and positive p-ANCA (1:160), leading to a revised diagnosis of eosinophilic granulomatosis with polyangiitis (EGPA) with mononeuritis multiplex. She responded well to corticosteroid therapy and methotrexate, with significant neurological improvement and no relapse observed at follow-up. This case highlights the diagnostic challenge of distinguishing EGPA from GBS in patients with acute neuropathy and highlights the importance of recognizing systemic features such as asthma, eosinophilia, and vasculitic signs to guide appropriate immunosuppressive treatment.

## Linked entities

- **Diseases:** allergic rhinitis (MONDO:0011786), eczema (MONDO:0004980), Guillain-Barré syndrome (MONDO:0016218)

## Full-text entities

- **Diseases:** asthma (MESH:D001249), EGPA (MESH:D014890), GBS (MESH:D020275), allergic rhinitis (MESH:D065631), sensory loss (MESH:C580162), Mononeuritis (MESH:D020422), eczema (MESH:D004485), numbness (MESH:D006987), vasculitic rashes (MESH:D005076), neuropathy (MESH:D009422), weakness (MESH:D018908), eosinophilia (MESH:D004802), foot drop (MESH:D020427), nasal polyps (MESH:D009298)
- **Chemicals:** methotrexate (MESH:D008727)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12754558/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12754558/full.md

## References

9 references — full list in the complete paper: https://tomesphere.com/paper/PMC12754558/full.md

---
Source: https://tomesphere.com/paper/PMC12754558